Using healthcare claims data to analyze the prevalence of BCR‐ABL‐positive chronic myeloid leukemia in France: A nationwide population‐based study

BACKGROUND: Data on Chronic Myeloid Leukemia (CML) prevalence are scarce. Here we provide an estimation of the prevalence of CML in France for the year 2014 using French national health insurance data. METHODS: We selected patients claiming reimbursement for tyrosine kinase inhibitors (TKI) or with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Med
Asıl Yazarlar: Foulon, Stéphanie, Cony‐Makhoul, Pascale, Guerci‐Bresler, Agnès, Delord, Marc, Solary, Eric, Monnereau, Alain, Bonastre, Julia, Tubert‐Bitter, Pascale
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2019
Konular:
Cancer Prevention
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6558491/
https://ncbi.nlm.nih.gov/pubmed/31038849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2200
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller